(Q41308059)

29 September 2017

1 reference

title

Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecin injection) in Japan (English)

1 reference

29 September 2017

1 reference

N Saijo

1

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

Annals of the New York Academy of Sciences

29 September 2017

published in

1 reference

29 September 2017

volume

803

1 reference

29 September 2017

page(s)

292-305

1 reference

Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

A limited sampling model for estimating pharmacokinetics of CPT-11 and its metabolite SN-38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB26399.X

10.1111/J.1749-6632.1996.TB26399.X

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference